Soleno Therapeutics Files 8-K on Financials
Ticker: SLNO · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, financial-condition, operations
TL;DR
SOLENO filed an 8-K. Standard financial update, no major news yet.
AI Summary
On February 27, 2025, Soleno Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates Soleno Therapeutics is providing updates on its financial condition and operations to the SEC, which is standard for public companies.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K report, which is standard for public companies and does not inherently indicate new risks.
Key Players & Entities
- SOLENO THERAPEUTICS INC (company) — Registrant
- February 27, 2025 (date) — Date of Report
- 100 Marine Parkway, Suite 400 Redwood City, CA 94065 (address) — Principal executive offices
- Capnia, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Soleno Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on Soleno Therapeutics, Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on February 27, 2025.
What is Soleno Therapeutics, Inc.'s principal executive office address?
Soleno Therapeutics, Inc.'s principal executive office is located at 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
What was Soleno Therapeutics, Inc.'s former company name?
Soleno Therapeutics, Inc.'s former company name was Capnia, Inc.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).